Innovative Lung-on-a-Chip with Immune Function Mimics a Living Organ

A pioneering lung-on-a-chip with an active immune system offers new insights into lung disease, infection response, and personalized therapies, transforming preclinical research and reducing animal testing.
Researchers at Georgia Tech and Vanderbilt University have developed a groundbreaking lung-on-a-chip that integrates a functional immune system, marking a significant advancement in biomedical engineering. This miniature model of the human lung, constructed on a flexible polymer chip, simulates the organ’s natural behavior, including expansion, blood circulation, and immune responses. Unlike previous models, this innovative platform enables scientists to observe immune cell movement and response within lung tissue, providing deeper insights into how the lungs combat infections and inflammatory diseases.
The development was led by Ankur Singh, director of Georgia Tech's Center for Immunoengineering, who described witnessing immune cells actively migrating through the chip as a transformative moment. Alongside Krishnendu Roy and colleagues, Singh’s team faced the challenge of maintaining viable immune cells within the chip, a hurdle they successfully overcame, resulting in a model where immune responses to pathogens like influenza could be closely studied.
This model not only responds accurately to infections but also offers a more human-relevant alternative to traditional animal testing, which often fails to fully replicate human lung responses. Singh emphasized the importance of this technology for understanding severe viral infections and developing effective treatments. The platform holds promise for studying other lung diseases such as asthma, cystic fibrosis, and lung cancer, and aims toward personalized medicine by creating patient-specific chips.
This innovation could revolutionize the way respiratory diseases are researched, allowing for better prediction of treatment efficacy and reducing reliance on animal models. It exemplifies a significant step toward more accurate, human-relevant preclinical testing and could ultimately lead to improved therapies and outcomes for millions suffering from lung ailments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Variations in Healthcare Provider Stigma Toward Substance Use Disorders by Condition and Provider Type
A new nationwide study uncovers significant variations in healthcare providers' stigma toward substance use disorders and underscores barriers to effective treatment across diverse medical settings.
Lifelong Development of Motor Skills: Using Percentile Reference Curves in Practice
Understanding motor skill development and decline across the lifespan is vital. This study introduces percentile reference curves for neuromotor functions, aiding early detection and intervention in motor performance issues from childhood to old age.
Neural Cells Assist Tumor Spread by Transferring Mitochondria to Cancer Cells
New research uncovers how neurons contribute to cancer progression by transferring mitochondria, enhancing tumor energy and metastatic potential, opening new avenues for treatment.
Why Have No Human Bird Flu Cases Been Reported in the US for Three Months?
The US has not reported any human bird flu cases in three months, prompting experts to question whether this is due to seasonal patterns, reduced testing, or underreporting. Ongoing surveillance aims to clarify the virus’s current status.